Circulating CTRP13 was examined in 88 male (20 healthy control, 22 T2DM patients, 22 NAFLD patients and 22 NAFLD+T2DM patients). This evidence concerns the gene C1QL3 and metabolic dysfunction-associated steatotic liver disease.